Research ArticleCancer

Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

Science Translational Medicine  08 Feb 2012:
Vol. 4, Issue 120, pp. 120ra17
DOI: 10.1126/scitranslmed.3003316

Log in to view the full text

Navigate This Article